SPG11: a consistent clinical phenotype in a family with homozygous Spatacsin truncating mutation
- 24 August 2007
- journal article
- case report
- Published by Springer Nature in neurogenetics
- Vol. 8 (4) , 301-305
- https://doi.org/10.1007/s10048-007-0095-z
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosumNature Genetics, 2007
- Spastic paraplegia with thin corpus callosum: description of 20 new families, refinement of the SPG11 locus, candidate gene analysis and evidence of genetic heterogeneityneurogenetics, 2006
- Hereditary Spastic Paraplegia With Thin Corpus CallosumArchives of Neurology, 2006
- Further Clinical and Genetic Characterization of SPG11: Hereditary Spastic Paraplegia with Thin Corpus CallosumNeuropediatrics, 2006
- Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamicsNature Reviews Molecular Cell Biology, 2004
- Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosumNeurology, 2004
- Clinical Progression and Genetic Analysis in Hereditary Spastic Paraplegia With Thin Corpus Callosum in Spastic Gait Gene 11 (SPG11)Archives of Neurology, 2004
- Recent advances in hereditary spastic paraplegiaCurrent Opinion in Neurology, 2001
- Linkage of autosomal recessive hereditary spastic paraplegia with mental impairment and thin corpus callosum to chromosome 15A13-15.2000
- Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15Neurology, 1999